Trial Condition(s):

Ischemia, Cerbral

Cerebral blood flow (CBF) with 40, 60 and 80 mg of Nimodipine.

Bayer Identifier:

Trial_0178

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

January1982

December1982

Phase

N/A

Could I receive a placebo?

Products

Nimotop (Nimodipine, BAYE9736)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Status

Locations	Status

For details, please refer to trial results

Additional Information

Not Available

Ischemia, Cerbral

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

17 Years

67 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information